Ghana vs Indonesia: HIV/AIDS deaths averted by antiretroviral therapy
Ghana
12,358 deaths
in 2024
Indonesia
14,389 deaths
in 2024
Ghana rank
20th
Indonesia rank
17th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Ghana
- Indonesia
How they compare
Indonesia currently reports 14,389 deaths against 12,358 deaths in Ghana, a difference of 2,031 deaths.
That makes Indonesia's figure about 1.2 times Ghana's.
The two have swapped places 6 times across 35 shared years of data; in 1990 it was Indonesia ahead.
Ghana ranks 20th and Indonesia ranks 17th of 157 countries.
Across the 4 decades both report, Ghana averaged higher in 3 and Indonesia in 1.
Head to head by decade
| Decade | Ghana | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | -0.0142 deaths | 0.0142 deaths | Ghana |
| 2000s | 1,525 deaths | 655.3 deaths | 870.09 deaths | Ghana |
| 2010s | 9,063 deaths | 6,279 deaths | 2,784 deaths | Ghana |
| 2020s | 11,466 deaths | 12,043 deaths | 576.38 deaths | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Ghana or Indonesia?
- Indonesia, at 14,389 deaths against 12,358 deaths in Ghana as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Ghana and Indonesia?
- 2,031 deaths, with Indonesia ahead.
- How many years of comparable data are there for Ghana and Indonesia?
- 35 years are reported by both, from 1990 to 2024.
- How do Ghana and Indonesia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Ghana ranks 20th and Indonesia ranks 17th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.